v3.26.1
BACKGROUND AND ORGANIZATION (Details Narrative)
Aug. 30, 2022
₨ / shares
shares
Dec. 31, 2025
$ / shares
shares
Dec. 31, 2024
$ / shares
shares
Oct. 25, 2024
$ / shares
shares
Mar. 17, 2022
$ / shares
shares
Sep. 21, 2018
$ / shares
shares
Oct. 05, 2017
$ / shares
shares
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock, shares authorized   400,000,000 400,000,000 3,389,169      
Common stock par value | $ / shares   $ 0.001 $ 0.001 $ 0.092      
Common stock, shares authorized   50,000,000 50,000,000 28,467,564      
Preferred stock, par value | $ / shares   $ 0.001 $ 0.001 $ 0.428      
Common stock, shares outstanding   108,147,731 86,782,908        
Pharmalectin India Pvt Ltd [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock, shares authorized 50,000            
Common stock par value | ₨ / shares ₨ 10            
Common stock, shares outstanding 41,020            
Outstanding shares held 41,000            
Outstanding shares percentage 99.95%            
Pharmalectin (BVI), Inc. [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock, shares authorized         50,000    
Common stock par value | $ / shares         $ 1.00    
Outstanding shares held         50,000    
NDPD Pharma Inc [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock, shares authorized             95,000,000
Common stock par value | $ / shares       0.091     $ 0.0001
Common stock, shares authorized             5,000,000
Preferred stock, par value | $ / shares       $ 0.427     $ 0.0001
Common stock, shares outstanding   15,000,000          
Common stock acquired percentage       100.00%      
Parent Company [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock, shares authorized           400,000,000 95,000,000
Common stock par value | $ / shares           $ 0.001 $ 0.0001
Common stock, shares authorized           50,000,000 5,000,000
Preferred stock, par value | $ / shares           $ 0.001 $ 0.0001
Pharmalectin, Inc. [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock, shares authorized             95,000,000
Common stock par value | $ / shares             $ 0.0001
Common stock, shares authorized             5,000,000
Preferred stock, par value | $ / shares             $ 0.0001
Common stock, shares outstanding   15,000,000